Home / Insights / The Pharma Letter: A year of two halves and what it means for life sciences in 2026

featured:

The Pharma Letter: A year of two halves and what it means for life sciences in 2026

Get regular updates in your inbox

Sign up to our mailing list today, to get access to sector-specific marketing insights and data-driven intel on the latest developments in the life sciences industry.

Fields marked with a * are required

First Name

Last Name

Company

Sector

Comments

By submitting this form you accept our Cookie Policy and privacy policy.

Capabilities

Sectors we work with

featured:

The Pharma Letter: A year of two halves and what it means for life sciences in 2026

PE hub: NorthEdge backed ramarketing picks up ISR market research

investors in healthcare: ramarketing acquires US market research firm ISR

Insider Media North East: ramarketing makes first acquisiton as it continues to accelerate US growth

mrweb: ramarketing Buys Pharma Outsourcing MR Specialist ISR

Pharma Focus America: ramarketing acquires US market research firm ISR